CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 24 enrolled
Drug / intervention
amoxicillin plus metronidazole +1 moredrug
Likely dose
amoxicillin plus metronidazole 250 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03727620
NCT03727620Phase 2Completed

Clinical Effects of Doxycycline in the Treatment of Aggressive Periodontitis: Comparative Clinical Study

Mohammed V Souissi University·interventional·Posted Nov 1, 2018·Updated Nov 1, 2018

In Brief

A Phase 2 clinical trial evaluating amoxicillin plus metronidazole and Doxycycline for Aggressive Periodontitis. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The aim of the study was to compare the clinical effects of systemic use of doxycycline to amoxicillin plus metronidazole as adjunctive treatment in nonsurgical debridement of aggressive periodontitis (AgP). Twenty four patients with aggressive periodontitis were enrolled in this clinical study. They all received oral hygiene instruction and full-mouth nonsurgical debridement using manual instruments. The test group received as adjunctive antibiotic treatment 200 mg of doxycycline the first day followed by 100 mg per day during 14 days. The control group received 500 of amoxicillin and 250 of metronidazole, three times a day for 7 days.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesMorocco
Collaborators--

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 1, 2018
Enrollment StartJan 6, 2014
Primary CompletionJun 6, 2014
Study CompletionDec 8, 2014
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.7 years ago

Interventions

amoxicillin plus metronidazoledrug

patients were administered 250 mg of Flagyl and 500 mg of Dyspamox, three times a day for 7 days

Doxycyclinedrug

patients were administered 200 mg of Longamycine the first day and 100 mg per day for 14 days